Based on the given data, the Total Pharmaceutical Market in Switzerland stood at 23.6% of generics in volume for the year 2023. The upward trend demonstrates consistent growth in the subsequent years: 24.1% in 2024, 24.7% in 2025, 25.3% in 2026, and 25.8% in 2027. The year-on-year growth indicates an increase of approximately 2.1% from 2023 to 2024, and between 2.4% to 2.0% for the following years. Over the last two years (2024-2026), the market shows positive growth with an average annual increment of around 2.2%. The compound annual growth rate (CAGR) from 2023 to 2027, stands at an average of 2.16% per year.

Future trends to watch:

Increasing adoption of generics due to cost-effectiveness and policy support
Technological advancements driving the efficiency of pharmaceutical manufacturing
Potential regulatory changes affecting the market dynamics for generics
Impact of healthcare reforms and budget allocations on generic drug consumption